The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate

Clin Prostate Cancer. 2002 Dec;1(3):182-7. doi: 10.3816/cgc.2002.n.021.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / pathology
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Celecoxib
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Double-Blind Method
  • Humans
  • Male
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Pyrazoles
  • Randomized Controlled Trials as Topic / methods
  • Research Design
  • Sulfonamides / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib